These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Tetrahydroaminoacridine or THA. Disputed value in Alzheimer's type dementia]. Chatellier G Rev Prat; 1993 Mar; 43(6):725-8. PubMed ID: 8341950 [No Abstract] [Full Text] [Related]
6. Alzheimer's disease: a new hope. Hasan MK; Mooney D W V Med J; 1994 Oct; 90(10):418-9. PubMed ID: 7801627 [TBL] [Abstract][Full Text] [Related]
8. [The cholinergic perspectives in the treatment of Alzheimer's disease: tacrine]. Royuela Rico A; Macías Fernández JA Rev Clin Esp; 1995 Jul; 195(7):473-8. PubMed ID: 7667523 [No Abstract] [Full Text] [Related]
9. [Treatment of Alzheimer's disease]. Soininen H Duodecim; 1997; 113(18):1739-46. PubMed ID: 10892065 [No Abstract] [Full Text] [Related]
10. Pharmacoepidemiology of tacrine in Alzheimer's disease. Begaud B; Haramburu F; Miremont G Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701 [No Abstract] [Full Text] [Related]
11. [Tacrine in the treatment of Alzheimer's disease]. Weinstein HC; Teunisse S; van Gool WA; van Crevel H Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487 [No Abstract] [Full Text] [Related]
12. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699 [TBL] [Abstract][Full Text] [Related]
13. [Clinical study of patients with Alzheimer's disease under treatment with tacrine]. García-López MT; Guardado-Santervás P Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762 [No Abstract] [Full Text] [Related]
14. Alzheimer's and Cognex. Steel JG N C Med J; 1995 Feb; 56(2):72-3. PubMed ID: 7741935 [No Abstract] [Full Text] [Related]
15. [Tacrine in Alzheimer's disease]. López de Munain A Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671 [No Abstract] [Full Text] [Related]
16. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease. Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977 [No Abstract] [Full Text] [Related]
17. Tacrine therapy for the dementia of Alzheimer's disease. Manning FC Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912 [TBL] [Abstract][Full Text] [Related]
18. [Tacrine]. Dávila C; Viteri C; de Castro P Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715 [TBL] [Abstract][Full Text] [Related]
19. [A gleam of hope for Alzheimer patients?]. Heinzl S Med Monatsschr Pharm; 1994 Jun; 17(6):163. PubMed ID: 8052165 [No Abstract] [Full Text] [Related]
20. Effect of tacrine in Alzheimer's disease: or non-effect? Broe GA; Creasey H Med J Aust; 1994 Sep; 161(6):348-9. PubMed ID: 8090107 [No Abstract] [Full Text] [Related] [Next] [New Search]